| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 10/17/2007 | CN101056543A Gamma-hendecene lactone, preparation method thereof and application in cosmetics and as food additive |
| 10/17/2007 | CN101054368A Method and apparatus for purification of furfuryl alcohol |
| 10/17/2007 | CN100343243C Manufacture of ascorbic acid esters |
| 10/17/2007 | CN100342862C Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 10/16/2007 | US7282608 Inhibitors of histone deacetylase |
| 10/16/2007 | US7282596 Reacting a Protected-Corey aldehyde with a Phosphonate compound, reduction |
| 10/16/2007 | US7282595 Therapy of adenocarcinoma of the colon and rectum |
| 10/16/2007 | US7282519 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| 10/16/2007 | US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents |
| 10/16/2007 | US7282320 For producing high memory capacity storage media |
| 10/16/2007 | US7282066 Processes for preparing and using tanning agents and preservatives |
| 10/11/2007 | WO2007115071A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 10/11/2007 | WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof |
| 10/11/2007 | WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 10/11/2007 | WO2007112842A1 Active ingredient combinations with insecticidal properties |
| 10/11/2007 | WO2007093539A3 Benzoyl-substituted alanines |
| 10/11/2007 | US20070238887 Chemo-enzymatic process for the preparation of escitalopram |
| 10/11/2007 | US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use |
| 10/11/2007 | DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system |
| 10/11/2007 | CA2648033A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 10/11/2007 | CA2647811A1 Substituted bicyclic derivative and use thereof |
| 10/10/2007 | EP1842843A1 Process for the synthesis of carboxylic acid alkyl esters |
| 10/10/2007 | EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 10/10/2007 | EP1399163B1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 10/10/2007 | EP1232150B1 Urea derivatives as anti-inflammatory agents |
| 10/10/2007 | CN101052631A Crystalline mycophenolate sodium |
| 10/10/2007 | CN101052630A Substituted heterocyclic compounds and uses thereof |
| 10/10/2007 | CN101052607A Method for purifying 1,4-butanediol |
| 10/10/2007 | CN101050209A Compound of eudesmane type sesquiterpene lactone with insecticidal activity extracted from Carpesium macrocephalum, and application |
| 10/10/2007 | CN101050208A Technique for producing usnic acid |
| 10/09/2007 | US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane |
| 10/09/2007 | US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/09/2007 | US7279158 Methods for the treatment of inflammatory joint disease |
| 10/04/2007 | WO2007111921A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
| 10/04/2007 | WO2007111176A1 Organic electroluminescence element material and organic electroluminescence element using such material |
| 10/04/2007 | WO2007111024A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 10/04/2007 | WO2007067581A8 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
| 10/04/2007 | WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
| 10/04/2007 | US20070232815 A 2,5-disubstituted furan having functional groups selected from a hydroxymethyl group, a formyl group and a carboxyl group, is oxidized with a metal permanganate in an alkaline environment containing an alkali metal or alkali earth metal hydroxide; non-catalytic quantitative synthesis in mild conditions |
| 10/04/2007 | US20070232813 Substituted Cyclohexadienals - Syntheses and Applications |
| 10/04/2007 | US20070232719 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers; dental materials, in particular as dental adhesives, fixing cements or filling composites; low polymerization shrinkage, good mechanical properties |
| 10/04/2007 | US20070232688 Novel sterol/stanol phosphorylnitroderivatives and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 10/04/2007 | US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 10/04/2007 | US20070232621 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 10/04/2007 | US20070232606 Compounds and Compositions as Cathepsin S Inhibitors |
| 10/04/2007 | US20070231839 N-(3-oxododecanoyl)-L-homoserine lactone, binding to carrier; used as vaccine or to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer; carrier molecule comprises a lysine-containing protein, such as bovine serum albumin |
| 10/04/2007 | US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 10/04/2007 | US20070228328 As-Indacen Derivatives |
| 10/04/2007 | DE102006014732A1 O-acylierte Hydroxycarbonsäureanhydride und ein Verfahren zu ihrer Herstellung O-acylated Hydroxycarbonsäureanhydride and a method for their preparation |
| 10/04/2007 | DE10129119B4 Kristalline Salze von Benzoylbenzofuran-Derivaten, insbesondere Crystalline salts of benzoylbenzofuran-derivatives, in particular von[2-(4-{1-[2-((S)-sec.-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]-methanoyl}-2,6-diiod-phenoxy)-ethyl]-diethylamino und [2-(4-{1-[(3-Methyl-2-(S)-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]- methanoyl}-2,6-diiodphenoxy)-ethyl]-diethylamino, deren Verwendung und Herstellung sowie diese Salze enthaltende Arzneimittel and [2- (4- {1 - [(3-methyl-2- (S) -Butoxycarbonylmethyl) benzofuran-3-carbonyl] - methanoyl} -2,6-diiodphenoxy) -ethyl] -diethylamino, their use and preparation and pharmaceutical compositions containing these salts |
| 10/04/2007 | CA2645487A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
| 10/03/2007 | EP1840116A1 Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid derivative |
| 10/03/2007 | EP1838690A2 Compounds with kv4 ion channel activity |
| 10/03/2007 | EP1838689A2 Conversion of 2,5-(hidroxymethyl)furaldehyde to 2,5-bis(hidroxymethyl)tetrahydofuran, purification and industrial uses of the product |
| 10/03/2007 | EP1838688A2 Preparation of 2,5-(hydroxymethyl)furaldehyde (hmf), derivatives thereof and levulinic acid from fructose as well as preparation of 2,5-bis-(hydroxymethyl)furan from 2,5-(hydroxymethyl)furaldehyde |
| 10/03/2007 | EP1838661A1 Norbornane based cycloaliphatic compounds containing methylene amine groups |
| 10/03/2007 | EP1838405A1 Method for producing phthalic anhydride that conforms to specifications |
| 10/03/2007 | EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 10/03/2007 | EP1539673B1 Process for the preparation of n -monosubstituted beta-amino alcohols |
| 10/03/2007 | EP1364933B1 Optical resolver and method of optically resolving alcohol with the same |
| 10/03/2007 | EP1339664B1 Production of butane tetracarboxylic acid derivatives by means of coupled electrosynthesis |
| 10/03/2007 | CN101048405A Aryl-substituted piperazine derivatives |
| 10/03/2007 | CN101048396A Process for the preparation of citalopram and escitalopram |
| 10/03/2007 | CN101048367A New tyrosine derivative as ppar gamma regulator |
| 10/03/2007 | CN101045664A Method for the separation and purifiction |
| 10/03/2007 | CN100340554C Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 10/03/2007 | CN100340553C Process for the preparation of SOTOLON |
| 10/03/2007 | CN100340547C New unsaturated oxime derivatives and the use thereof as latent acids |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276573 Polymerizing tetrahydrofuran in the presence of at least one telogen and/or of a comonomer over an acidic catalyst, wherein the polymerization reactor is started up using a mixture of polytetrahydrofuran, the mono- or diesters of polytetrahydrofuran and/or THF copolymers, tetrahydrofuran, comonomer |
| 10/02/2007 | CA2096407C Retroviral protease inhibitors |
| 09/27/2007 | WO2007109334A2 Sip receptor modulating compounds and use thereof |
| 09/27/2007 | WO2007108999A2 Production of 2,5-dihydrofurans and analogous compounds |
| 09/27/2007 | WO2007108483A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same |
| 09/27/2007 | WO2007108442A1 Agent for prevention/treatment of irritable bowel syndrome |
| 09/27/2007 | WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | WO2007107023A1 Flavorant and fragrance compounds |
| 09/27/2007 | WO2007107008A1 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
| 09/27/2007 | WO2007003200A3 High yield synthesis methods for producing organic salts of strontium |
| 09/27/2007 | US20070225365 Cetp Inhibitors |
| 09/27/2007 | US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/27/2007 | US20070225266 Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections |
| 09/27/2007 | US20070220688 Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds |
| 09/27/2007 | CA2679980A1 S1p receptor modulating compounds and use thereof |
| 09/27/2007 | CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | CA2644181A1 Prophylactic or therapeutic agent for irritable bowel syndrome |
| 09/26/2007 | EP1837024A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 09/26/2007 | EP1836182A2 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 09/26/2007 | EP1836181A1 Method and devices for the continuous processing of renewable raw materials |
| 09/26/2007 | EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/26/2007 | EP1836161A2 Methods and compositions for treating amyloid-related diseases |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/26/2007 | EP1438040B1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
| 09/26/2007 | CN101044253A Process for producing leather and compounds suitable therefor |
| 09/26/2007 | CN101044139A Cyclopamine analogues and methods of use thereof |
| 09/26/2007 | CN101044131A Androgen modulators |